Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk

Acta Myologica

Volumn 28, Issue 1, 2009, Pages 2-11

  Lamperti, C ^a   Zeviani, M ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Mitochondrial disorders; Mitochondrial DNA; MtDNA depletion; MtDNA multiple deletions; Oxidative phosphorylation

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; DNA POLYMERASE; HELICASE; MITOCHONDRIAL DNA; PROTEIN PEO 1; PROTEIN POLG 1; PYRIMIDINE NUCLEOSIDE; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CATALYSIS; CLINICAL FEATURE; ENCEPHALOMYOPATHY; EXTERNAL OPHTHALMOPLEGIA; GENE MUTATION; GENOMICS; HUMAN; MITOCHONDRIAL DNA DEPLETION SYNDROME; OXIDATIVE PHOSPHORYLATION; POINT MUTATION;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; CYTOCHROME REDUCTASES; DISEASE PROGRESSION; DNA; DNA HELICASES; DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; GENE DELETION; GTP PHOSPHOHYDROLASES; HUMANS; MITOCHONDRIAL ENCEPHALOMYOPATHIES; THYMIDINE PHOSPHORYLASE;

EID: 70349488018     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Contamine V, Picard M. Maintenance and integrity of the mitochondrial genome: a plethora of nuclear genes in the budding yeast. Microbiol Mol Biol Rev 2000;64:281-315. (Pubitemid 30412676)
2. Clayton DA. Vertebrate mitochondrial DNA - a circle of surprises. Exp Cell Res 2000;255:4-9.
3. Holt IJ, Lorimer HE, Jacobs HT. Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA. Cell 2000;100:515-524
4. Zeviani M, Servidei S, Gellera C, et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D loop region. Nature 1989;339:309-311 (Pubitemid 19130698)
5. Servidei S, Zeviani M, Manfredi G, et al. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology 1991;41:1053-1059
6. Hirano M, Marti R, Ferreiro-Barros C, et al. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Dev Biol 2001;12:417-427 (Pubitemid 33586198)
7. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008;131:338-351
8. Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008;13:329-337 (Pubitemid 351197604)
9. Yuzaki M, Ohkoshi N, Kanazawa I, et al. Multiple deletions in mitochondrial DNA at direct repeats of non-D-loop regions in cases of familial mitochondrial myopathy. Biochem Biophys Res Commun 1989;164:1352-1357 (Pubitemid 19283993)
10. Mizusawa H, Watanabe M, Kanazawa I, et al. Familial mitochondrial myopathy associated with peripheral neuropathy: partial deficiencies of complex 1 and complex 4. J Neurol Sci 1988;86:171-184 (Pubitemid 18217235)
11. Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002;52:211-219 (Pubitemid 34810602)
12. Agostino A, Valletta L, Chinnery PF, et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003;60:1354-1356
13. Di Fonzo A, Ronchi D, Lodi T, et al. The mitochondrial disulfide relay system protein GFER is mutated in autosomal-recessive myopathy with cataract and combined respiratory-chain deficiency. Am J Hum Genet 2009;84:594-604. Epub 2009 Apr 30.
14. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-727 (Pubitemid 24130006)
15. Giordano C, Sebastiani M, De Giorgio R, et al. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 2008;174:1120-1128 Epub 2008 Sep 11.
16. Marti R, Verschuuren JJ, Buchman A, et al. Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol 200;58:649-652
17. Naviaux RK, Nyhan WL, Barshop BA, et al. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol 1999;45:54-58
18. Van Goethem G, Martin JJ, Dermaut B, et al. POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003;13:133-142 (Pubitemid 36140008)
19. Hakonen AH, Goffart S, Marjavaara S, et al. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 2008;17:3822-3835
20. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005;354:162-168
21. Vu TH, Tanji K, Holve SA, Bonilla E, et al. Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome? Hepatology 2001;34:116-120
22. Moraes CT, Shanske S, Tritschler HJ, et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991;48:492-501. (Pubitemid 21903047)
23. Galbiati S, Bordoni A, Papadimitriou D. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol 2006;34:177-185 (Pubitemid 43295382)
24. Oskoui M, Davidzon G, Pascual J, et al. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol 2006;63:1122-1126 (Pubitemid 44232318)
25. Bourdon A, Minai L, Serre V, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007;39:776-780 (Pubitemid 46848590)
26. Bornstein B, Area E, Flanigan KM, et al. Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene. Neuromuscul Disord 2008;18:453-459
27. Elpeleg O, Miller C, Hershkovitz E, et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 2005;76:1081-1086 (Pubitemid 40705442)
28. Carrozzo R, Dionisi-Vici C, Steuerwald U, et al. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 2007;13:862-874 (Pubitemid 46410746)
29. Ostergaard E, Hansen FJ, Sorensen N, et al. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 2007;130:853-861 (Pubitemid 46410742)
30. Kaukonen J, Juselius JK, Tiranti V, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-785 (Pubitemid 30650199)
31. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001;28:223-231 (Pubitemid 32626024)
32. Van Goethem G, Dermaut B, Lofgren A, et al. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001;28:211-212 (Pubitemid 32626018)
33. Palmieri L, Alberio S, Pisano I, et al. Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet 2005;14:3079-3088 (Pubitemid 41535472)
34. Galassi G, Lamantea E, Invernizzi F, et al. Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy. Neuromuscul Disord 2008;18:465-470
35. Nikali K, Suomalainen A, Saharinen J, et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005;14:2981-2990 (Pubitemid 41535463)
36. Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004;364:875-882 (Pubitemid 39221065)
37. Filosto M, Mancuso M, Nishigaki Y, et al. Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. Arch Neurol 2003;60:1279-1284 (Pubitemid 37099636)
38. Invernizzi F, Varanese S, Thomas A, et al. Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. Neuromuscul Disord 2008;18:460-464
39. Van Goethem G, Martin JJ, Dermaut B, et al. POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003;13:133-142 (Pubitemid 36140008)
40. Davidzon G, Mancuso M, Ferraris S, et al. POLG mutations and Alpers syndrome. Ann Neurol 2005;57:921-923
41. Ferrari G, Lamantea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005;128:723-731 (Pubitemid 40516911)
42. Van Goethem G, Luoma P, Rantamaki M, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004;63:1251-1257 (Pubitemid 39350026)
43. Winterthun S, Ferrari G, He L, et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 2005;64:1204-1208 (Pubitemid 40490519)
44. Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006;129:1674-1684 (Pubitemid 43999402)
45. Longley MJ, Clark S, Yu Wai Man C, et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006;78:1026-1034 (Pubitemid 43787693)
46. Duvezin-Caubet S, Jagasia R, Wagener J, et al. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 2006;281:37972-37979 (Pubitemid 46042101)
47. Lee YJ, Jeong SY, Karbowski M, et al. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 2004;15:5001-5011
48. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211-215 (Pubitemid 30764506)
49. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-210 (Pubitemid 30764505)
50. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Scand 1959;37:1-146.
51. Milone M, Younge BR, Wang J, et al. Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Mitochondrion 2009;9:279-281
52. Zeviani M. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape. Brain 2008;131:314-317 (Pubitemid 351197626)
53. Mesecke N, Terziyska N, Kozany C, et al. A disulfide relay system in the intermembrane space of mitochondria that mediates protein import. Cell 2005;121:1059-1069 (Pubitemid 40884396)
54. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-692 (Pubitemid 129506238)
55. Hirano M, Lagier-Tourenne C, Valentino ML, et al. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 2005;354:152-156 (Pubitemid 41116695)
56. Spinazzola A, Marti R, Nishino I, et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002;277:4128-4133 (Pubitemid 34968672)
57. Marti R, Spinazzola A, Tadesse S, et al. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 2004;50:120-124 (Pubitemid 38125707)
58. Ferraro P, Pontarin G, Crocco L, et al. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 2005;280:24472-24480 (Pubitemid 40934532)
59. Pontarin G, Ferraro P, Valentino ML, et al. Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 2006;281:22720-22728 (Pubitemid 44242300)
60. Yavuz H, Ozel A, Christensen M, et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007;64:435-438 (Pubitemid 46425702)
61. Hirano M, Marti R, Casali C, et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006;67:1458-1460 (Pubitemid 44632073)
62. Lara MC, Weiss B, Illa I, et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006;67:1461-1463 (Pubitemid 44632074)
63. Saada A, Shaag A, Mandel H, et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001;29:342-344 (Pubitemid 33096463)
64. Sarzi E, Goffart S, Serre V, et al. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 2007;62:579-587
65. Hakonen AH, Isohanni P, Paetau A, et al. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007;130:3032-3040 (Pubitemid 350033977)
66. Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001;29:337-341 (Pubitemid 33096462)
67. Salviati L, Sacconi S, Mancuso M, et al. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 2002;52:311-316 (Pubitemid 35001497)
68. Tadiboyina VT, Rupar A, Atkison P, et al. Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria. Am J Med Genet 2005;135A:289-291 (Pubitemid 40756655)
69. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006;38:570-575
70. Wong LJ, Brunetti-Pierri N, Zhang Q, et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 2007;46:1218-1227 (Pubitemid 350144786)
71. Spinazzola A, Santer R, Akman OH, et al. Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations. Arch Neurol 2008;65:1108-1113
72. Karadimas CL, Vu TH, Holve SA, et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 2006;79:544-548 (Pubitemid 44384263)
73. Spinazzola A, Massa V, Hirano M, et al. Lack of founder effect for an identical mtDNA depletion syndrome (MDS)-associated MPV17 mutation shared by Navajos and Italians. Neuromuscul Disord 2008;18:315-318
74. Ashley N, Adams S, Slama A, et al. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. Hum Mol Genet 2007;16:1400-1411 (Pubitemid 47055114)
75. Wang X, Salinas K, Zuo X, et al. Dominant membrane uncoupling by mutant adenine nucleotide translocase in mitochondrial diseases. Hum Molec Genet 2008;17:4036-4044 (Pubitemid 352762862)